Related Experiment Video
Updated: May 7, 2026

Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy
Published on: October 25, 2024
Cyclic changes and relationship between peripheral and endometrial NK cells from women with repeated failure after
Yang Zhang1, Joanne Kwak-Kim, Donghui Huang
1Family Planning Research Institute, Center for Reproductive Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Hospital for Reproductive Medicine, Affiliated to Shandong University, Jinan, China.
Problem:
Cyclic changes of peripheral natural killer (pNK) cells and/or endometrial NK (eNK) cells during menstrual cycle remain controversial, and their relationship remains uncertain.
Method Of Study:
Peripheral blood and endometrial biopsies were simultaneously obtained from women (n = 23) undergoing artificial insemination with donor sperm (AID) for at least three cycles at both proliferative (days 9-11) and secretory phases (days 20-23) of menstrual cycle. The percentages of CD3(-) CD56(+), CD3(-) CD56(dim) CD16(+), CD3(-) CD56(bright) CD16(-) pNK, and eNK cell subsets within lymphocytes were determined by three-color flow cytometry. The correlation between the percentages of pNK and eNK cells was further analyzed by Spearman's test.
Results:
The percentages of CD3(-) CD56(+), CD3(-) CD56(dim) CD16(+), and CD3(-) CD56(bright ) CD16(-) pNK cells were not statistically different between the proliferative and secretory phases (P > 0.05, respectively). However, the percentages of CD3(-) CD56(+) and CD3(-) CD56(bright ) CD16(-) eNK cells were significantly decreased at the secretory phase, compared with those in the proliferative phase (P < 0.05, respectively). No correlation between the percentages of all pNK cell parameters and those of CD3(-) CD56(bright ) CD16(-) eNK cells (the major subset of NK cells in uterus) was found in the same women throughout the menstrual cycle (P > 0.05).
Conclusion:
We found a menstrual-cycle-dependent change in the percentage of eNK cells in women undergoing AID treatment, but not pNK cells. Moreover, the percentage of pNK cells may not reflect that of eNK cells during menstrual cycle.
More Related Videos
07:46Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
Published on: October 13, 2023
05:16Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021